Healthpeak Properties, Inc.
DOCReal Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024.
- Revenue
- +16.3%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +2.75%
Quarter to September 2026, against a year earlier
After hours trading: 19.44, up 0.99%, last trade 7:39pm Eastern.
Follow DOC
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 1.49% in Q3 FY26, the lowest of these four quarters. ROE, at 3.97%, is far above it because equity is small against the capital the business uses.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | 0.8% | 2.5% | 2.7% | 4.0% |
| ROIC | 1.9% | 1.6% | 1.7% | 1.5% |
Debt
Net debt is 23.06× a year’s EBITDA. Debt is 0.87× equity, against 1.21× in Q4 FY25.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 1.2× | 1.2× | 1.1× | 0.9× |
| Net debt / EBITDA | 24.9× | 25.6× | 21.7× | 23.1× |
Cash cycle, in days
Customers pay in 9 days and suppliers are paid in 206. Suppliers fund 197 days of working capital.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Cash cycle | −222 | −196 | −191 | −197 |
| Days to pay suppliers | 232 | 208 | 200 | 206 |
| Days to be paid | 10 | 12 | 9 | 9 |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has grown 9.61%; book value has grown 33.6%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 0.1× | −0.1× | −5.0× |
| Revenue | 1.0× | 1.0× | 1.1× | 1.1× |
| Book value | 1.0× | 1.1× | 1.2× | 1.3× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.82% | 2.48% | 2.69% | 3.97% | |
Piotroski F-Score |
4 | 5 | 6 | 7 | |
| 0.35% | 1.07% | 1.17% | 1.80% | ||
ROIC |
1.86% | 1.65% | 1.71% | 1.49% | |
Return on Tangible Assets |
0.42% | 1.22% | 1.33% | 2.02% | |
Average Days of Receivables |
10.13 | 11.62 | 8.93 | 9.04 | |
Free Cash Flow per Share |
0.49 | 0.06 | (0.03) | (2.45) | |
Free Cash Flow |
339.32 | 44.73 | (19.33) | (1,686.65) | |
Capital Expenditures |
(912.63) | (1,188.68) | (1,250.35) | (2,957.18) | |
| Other line items | |||||
Cash ROIC |
1.83% | 0.22% | (0.09%) | (8.12%) | |
Accounts Receivable Turnover |
36.39 | 35.82 | 41.88 | 39.09 | |
Accounts Payable Turnover |
1.56 | 1.76 | 1.75 | 1.77 | |
Average Days of Payables |
232.27 | 207.66 | 200.30 | 206.45 | |
Tax Rate |
(0.03) | (0.02) | (0.01) | (0.01) | |
Selling, General and Administrative Expense of Revenue |
3.20% | 3.09% | 3.07% | 3.08% | |
Share Based Compensation of Revenue |
0.51% | 0.67% | 0.75% | 0.75% | |
Interest Coverage |
1.70 | 1.50 | 1.44 | 1.36 | |
Operating CF/Net income |
17.76 | 5.57 | 5.07 | 3.37 | |
Depreciation/Fixed assets |
0.06 | 0.06 | 0.06 | 0.06 | |
Capex/Depreciation |
(0.96) | (1.22) | (1.26) | (2.88) | |
Revenue per Share |
4.06 | 4.13 | 4.28 | 4.44 | |
Operating CF per Share |
1.80 | 1.77 | 1.78 | 1.84 | |
Capex per Share |
(1.31) | (1.71) | (1.81) | (4.29) | |
Capex to Sales |
0.32 | 0.41 | 0.42 | 0.96 |